- Home
- SABS vs DUO Comparison
SABS vs DUO Comparison
Compare SABS & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- DUO
- Stock Information
- Founded
- SABS 2014
- DUO 2011
- Country
- SABS United States
- DUO China
- Employees
- SABS N/A
- DUO N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- DUO Real Estate
- Sector
- SABS Health Care
- DUO Finance
- Exchange
- SABS Nasdaq
- DUO Nasdaq
- Market Cap
- SABS 19.0M
- DUO 17.1M
- IPO Year
- SABS N/A
- DUO 2019
- Fundamental
- Price
- SABS $1.10
- DUO $0.27
- Analyst Decision
- SABS Strong Buy
- DUO
- Analyst Count
- SABS 5
- DUO 0
- Target Price
- SABS $11.40
- DUO N/A
- AVG Volume (30 Days)
- SABS 39.3K
- DUO 2.1M
- Earning Date
- SABS 05-19-2025
- DUO 04-17-2025
- Dividend Yield
- SABS N/A
- DUO N/A
- EPS Growth
- SABS N/A
- DUO N/A
- EPS
- SABS N/A
- DUO N/A
- Revenue
- SABS $1,322,410.00
- DUO $37,352,654.00
- Revenue This Year
- SABS N/A
- DUO N/A
- Revenue Next Year
- SABS $25.00
- DUO N/A
- P/E Ratio
- SABS N/A
- DUO N/A
- Revenue Growth
- SABS N/A
- DUO 6.61
- 52 Week Low
- SABS $1.11
- DUO $0.27
- 52 Week High
- SABS $5.01
- DUO $4.67
- Technical
- Relative Strength Index (RSI)
- SABS 28.53
- DUO 25.57
- Support Level
- SABS $1.11
- DUO $0.27
- Resistance Level
- SABS $1.80
- DUO $0.31
- Average True Range (ATR)
- SABS 0.14
- DUO 0.03
- MACD
- SABS -0.02
- DUO 0.00
- Stochastic Oscillator
- SABS 6.70
- DUO 1.35
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.